{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Avenue Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"ATXI"},"Address":{"label":"Address","value":"1140 AVENUE OF THE AMERICAS 9TH FLOOR, NEW YORK, New York, 10036, United States"},"Phone":{"label":"Phone","value":"+1 781 652-4500"},"Industry":{"label":"Industry","value":" Medicinal Chemicals and Botanical Products "},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain."},"CompanyUrl":{"label":"Company Url","value":"https://www.avenuetx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alexandra MacLean","title":"Chief Executive Officer"},{"name":"David Jin","title":"Chief Operating &amp; Financial Officer, Secretary"},{"name":"Scott A. Reines","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}